| Tue, 21 Sep 2021 11:52:26: | Aerie CEO exits days after downplaying midphase eye disease flop
|
| Tue, 21 Sep 2021 10:38:17: | BioMed bets $1.2B to ease U.K. life science capacity crunch
|
| Mon, 20 Sep 2021 14:25:49: | ESMO: Syros targets KRAS-mutant cancer as CDK7 inhibitor shows early promise
|
| Mon, 20 Sep 2021 10:11:15: | Bankrolled by Pfizer and Bayer, Pyxis files for $100M IPO to take cancer drugs into the clinic
|
| Fri, 17 Sep 2021 09:00:50: | ESMO: Mirati pulls away from Amgen in colorectal cancer with rival KRAS drug
|
| Fri, 17 Sep 2021 07:52:39: | AstraZeneca taps Dana-Farber's Rahma to lead its GI oncology work
|
| Fri, 17 Sep 2021 07:27:59: | ESMO: Daiichi unveils first early peek at next-gen ADC as analysts see strong data against rivals
|
| Thu, 16 Sep 2021 15:33:07: | New insights into bats' immunity could point to therapeutic approaches for fighting COVID-19
|
| Thu, 16 Sep 2021 15:23:25: | ESMO: Novartis links prostate cancer drug to improved pain, quality of life as regulatory filings near
|
| Thu, 16 Sep 2021 12:28:32: | ESMO: Zymeworks lays down marker in fight to unseat Herceptin
|
| Thu, 16 Sep 2021 08:44:08: | Aerie tries to wash over failure of midstage eye disease drug, but investors see right through it
|
| Wed, 15 Sep 2021 19:12:54: | How do faulty genes drive cancer? There's a surprising immune connection, study finds
|
| Wed, 15 Sep 2021 13:58:39: | Newly discovered immune cells block melanoma metastasis in mice and could inspire new treatments
|
| Wed, 15 Sep 2021 13:17:06: | Abingworth, Gimv and Pfizer back stealthy Swiss startup's $61M round to crack gene therapy delivery
|
| Wed, 15 Sep 2021 12:27:46: | Novo Nordisk Foundation teams up with Broad Institute, Harvard for diabetes, obesity research hub
|
| Wed, 15 Sep 2021 12:01:21: | Theravance axing 75% of staff, slashing R&D budget after flunking phase 3
|
| Wed, 15 Sep 2021 05:28:37: | Moderna, AbCellera join forces to tackle major mRNA opportunity
|
| Tue, 14 Sep 2021 15:36:34: | Sanofi dumps Principia Biopharma's San Francisco labs with plans to immediately cut 38 jobs
|
| Tue, 14 Sep 2021 12:40:10: | After 3 big exits, Lightstone snags largest fund yet with $375M geared toward next biotechs, medtechs
|
| Tue, 14 Sep 2021 12:38:30: | RedHill BioPharma follows familiar biotech path after COVID-19 drug fails in severe patients
|
| Tue, 14 Sep 2021 11:54:03: | UPDATE: Pfizer and Trillium: How a $25M investment led to a $2.3B buyout
|
| Tue, 14 Sep 2021 07:37:12: | Another death blights Astellas' $3B Audentes buy as FDA slaps clinical hold on the test
|
| Mon, 13 Sep 2021 15:40:24: | Kapeller's Rome bags $77M to strike gold in the backwaters of the genome
|
| Mon, 13 Sep 2021 13:37:48: | Provention will wait for FDA to 'opine' on new data after teplizumab rejection, eyes Q4 for further talks
|
| Mon, 13 Sep 2021 13:18:20: | Attacking Alzheimer's by blocking 'frustrated' amyloid proteins before they form plaques
|
